Adefovir Dipivoxil Tablets

Effects and efficacy:
Adefovir dipivoxil is suitable for the treatment of adult chronic hepatitis B patients with evidence of active replication of hepatitis B virus, accompanied by persistent elevation of serum aminotransferase (ALT or AST) or liver function compensation with active histological lesions of the liver. This product can be used to alleviate organ physiological changes caused by viral replication, such as diseases that affect liver cell damage and liver function damage or abnormalities after chronic hepatitis B. In addition, Adefovir dipivoxil has clinical experience in treating AIDS.

Dosage and administration:
Patients must use Adefovir dipivoxil under the guidance of a physician with experience in treating chronic hepatitis B. Usage: Oral, before or after meals. Food does not affect the pharmacokinetics of Adefovir. Dosage: The recommended dose of Adefovir dipivoxil for adults (18-65 years old) is 1 tablet once a day. The optimal course of treatment has not yet been determined, and do not exceed the recommended dose. Please follow the doctor’s advice for medication details. Patients should regularly monitor hepatitis B biochemical indicators, virological indicators and serum markers at least once every 6 months. Mild renal impairment (creatinine clearance ≥ 50ml/min) has little effect on the metabolism of adefovir dipivoxil. Patients with moderate and severe renal impairment (creatinine clearance < 50ml/min) or patients with end-stage renal disease need hemodialysis and adjustment of medication intervals. Moderate and severe liver damage has little effect on the pharmacokinetics of adefovir dipivoxil and does not require dosage adjustment. Drug contraindications: Athletes who are allergic to this product should not use it with caution Related dosage forms: Capsules, tablets